Topline Results from Tofersen Phase 3 Study and its Open Label Extension in SOD1-ALS to be Presented at the American Neurological Association Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. COHR

Go back to Topline Results from Tofersen Phase 3 Study and its Open Label Extension in SOD1-ALS to be Presented at the American Neurological Association Annual Meeting
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 219.07 +3.57 (1.66%)
Previous Close $215.50    52 Week High $333.65 
Open $216.14    52 Week Low $223.02 
Day High $221.92    P/E 28.05 
Day Low $214.59    EPS $7.81 
Volume 928,547       

(NASDAQ: IONS) Delayed: 44.90 +0.46 (1.04%)
Previous Close $44.44    52 Week High $62.68 
Open $44.95    52 Week Low $19.59 
Day High $45.25    P/E N/A 
Day Low $44.20    EPS $0.00 
Volume 4,520,763